These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
278 related items for PubMed ID: 23022640
21. Beyond nimodipine: advanced neuroprotection strategies for aneurysmal subarachnoid hemorrhage vasospasm and delayed cerebral ischemia. Luzzi S, Bektaşoğlu PK, Doğruel Y, Güngor A. Neurosurg Rev; 2024 Jul 05; 47(1):305. PubMed ID: 38967704 [Abstract] [Full Text] [Related]
22. Effect of fasudil hydrochloride, a protein kinase inhibitor, on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage. Zhao J, Zhou D, Guo J, Ren Z, Zhou L, Wang S, Xu B, Wang R. Neurol Med Chir (Tokyo); 2006 Sep 05; 46(9):421-8. PubMed ID: 16998274 [Abstract] [Full Text] [Related]
23. Resistant vasospasm in subarachnoid hemorrhage treated with continuous intraarterial nimodipine infusion. Doukas A, Petridis AK, Barth H, Jansen O, Maslehaty H, Mehdorn HM. Acta Neurochir Suppl; 2011 Sep 05; 112():93-6. PubMed ID: 21691994 [Abstract] [Full Text] [Related]
24. Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results. Bele S, Proescholdt MA, Hochreiter A, Schuierer G, Scheitzach J, Wendl C, Kieninger M, Schneiker A, Bründl E, Schödel P, Schebesch KM, Brawanski A. Acta Neurochir (Wien); 2015 Dec 05; 157(12):2041-50. PubMed ID: 26439105 [Abstract] [Full Text] [Related]
25. Endovascular treatment: balloon angioplasty versus nimodipine intra-arterial for medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Aburto-Murrieta Y, Marquez-Romero JM, Bonifacio-Delgadillo D, López I, Hernández-Curiel B. Vasc Endovascular Surg; 2012 Aug 05; 46(6):460-5. PubMed ID: 22914892 [Abstract] [Full Text] [Related]
26. Long-term health-related quality of life after spontaneous nontraumatic subarachnoid hemorrhage: self and proxy reports in a 10-year period. Kapapa T, Woischneck D, Tjahjadi M. World Neurosurg; 2014 Jan 05; 81(1):105-9. PubMed ID: 23046914 [Abstract] [Full Text] [Related]
27. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm. Hänggi D, Eicker S, Beseoglu K, Behr J, Turowski B, Steiger HJ. Cent Eur Neurosurg; 2009 May 05; 70(2):61-7. PubMed ID: 19711257 [Abstract] [Full Text] [Related]
28. Effects of dose-response of topical administration of nimodipine on cerebral vasospasm after subarachnoid hemorrhage in rabbits. Yin YH, Wang F, Pan YH, Wang Y, Wang Y, Luo QZ, Jiang JY. Am J Med Sci; 2009 Feb 05; 337(2):123-5. PubMed ID: 19214028 [Abstract] [Full Text] [Related]
29. Dynamic CT perfusion imaging in subarachnoid hemorrhage-related vasospasm. Laslo AM, Eastwood JD, Chen FX, Lee TY. AJNR Am J Neuroradiol; 2006 Mar 05; 27(3):624-31. PubMed ID: 16552006 [Abstract] [Full Text] [Related]
30. [Cerebral vasospasm after subarachnoid hemorrhage. Current possibilities of prevention and treatment]. Stachura K, Danilewicz B. Przegl Lek; 2002 Mar 05; 59(1):46-8. PubMed ID: 12108047 [Abstract] [Full Text] [Related]
31. Symptomatic Cerebral Vasospasm after Spontaneous Subarachnoid Hemorrhage: Comparison of Single and Multiple Intra-arterial Treatment with Respect to the Functional Outcome. Neumann A, Ditz C, Schacht H, Aulmann L, Tronnier VM, Schramm P, Küchler JN. J Neurol Surg A Cent Eur Neurosurg; 2020 May 05; 81(3):220-226. PubMed ID: 31777052 [Abstract] [Full Text] [Related]
32. Continuous intra-arterial nimodipine infusion as rescue treatment of severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Anthofer J, Bele S, Wendl C, Kieninger M, Zeman F, Bruendl E, Schmidt NO, Schebesch KM. J Clin Neurosci; 2022 Feb 05; 96():163-171. PubMed ID: 34789415 [Abstract] [Full Text] [Related]
33. Vasodilatory effects of tadalafil in an animal model of cerebral vasospasm: Comparative analysis with oral nimodipine. Youm JY, Park B, Park KH, Il Won Y, Byoun HS, Lim J. Clin Neurol Neurosurg; 2023 Sep 05; 232():107857. PubMed ID: 37423086 [Abstract] [Full Text] [Related]
34. Nimodipine attenuation of early brain dysfunctions is partially related to its inverting acute vasospasm in a cisterna magna subarachnoid hemorrhage (SAH) model in rats. Zhao WJ, Wu C. Int J Neurosci; 2012 Oct 05; 122(10):611-7. PubMed ID: 22694164 [Abstract] [Full Text] [Related]
35. Long-Term, Continuous Intra-Arterial Nimodipine Treatment of Severe Vasospasm After Aneurysmal Subarachnoid Hemorrhage. Hockel K, Diedler J, Steiner J, Birkenhauer U, Danz S, Ernemann U, Schuhmann MU. World Neurosurg; 2016 Apr 05; 88():104-112. PubMed ID: 26732964 [Abstract] [Full Text] [Related]
36. Intra-arterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid haemorrhage - neurological and radiological outcome. Samuelsson J, Sunila M, Rentzos A, Nilsson D. Neuroradiol J; 2022 Apr 05; 35(2):213-219. PubMed ID: 34350797 [Abstract] [Full Text] [Related]
37. The effects of intravenous cilostazol and nimodipine on cerebral vasospasm after subarachnoid hemorrhage in an experimental rabbit model. Bilginer B, Onal MB, Narin F, Soylemezoglu F, Ziyal IM, Ozgen T. Turk Neurosurg; 2009 Oct 05; 19(4):374-9. PubMed ID: 19847758 [Abstract] [Full Text] [Related]
38. Results of an International Survey on the Investigation and Endovascular Management of Cerebral Vasospasm and Delayed Cerebral Ischemia. Hollingworth M, Chen PR, Goddard AJ, Coulthard A, Söderman M, Bulsara KR. World Neurosurg; 2015 Jun 05; 83(6):1120-1126.e1. PubMed ID: 25681601 [Abstract] [Full Text] [Related]
39. Side Effects of Long-Term Continuous Intra-arterial Nimodipine Infusion in Patients with Severe Refractory Cerebral Vasospasm after Subarachnoid Hemorrhage. Kieninger M, Flessa J, Lindenberg N, Bele S, Redel A, Schneiker A, Schuierer G, Wendl C, Graf B, Silbereisen V. Neurocrit Care; 2018 Feb 05; 28(1):65-76. PubMed ID: 28685393 [Abstract] [Full Text] [Related]